FINWIRES · TerminalLIVE
FINWIRES

ACADIA Pharmaceuticals' Q2 Daybue Sales Beat on Stix Formulation Uptake Supports Improved Outlook, RBC Says

By

ACADIA Pharmaceuticals' (ACAD) Daybue sales beat in Q2 due to the Stix formulation uptake on a better tolerability profile support an improved outlook, while Nuplazid to treat hallucinations linked with Parkinson's disease continues to perform solidly, RBC Capital Markets said in a research report emailed Wednesday.

An expected European Union launch in Q4 in Germany, followed by other countries, and with 60% of June US scripts being for Stix, could support 2026 sales of up to $500 million, according to the note.

The company's Remlifanserin to treat hallucinations related to Alzheimer's disease is now the near-term focal point, with trial enrolment complete and readout window narrowing, analysts wrote.

The brokerage said it reiterated its outperform rating on the stock and boosted its price target to $37 per share from $36.

Price: $28.69, Change: $+1.54, Percent Change: +5.67%

Related Articles

Wire

Zeta Global Swings to Q2 Earnings, Revenue Rises; Shares Drop After Hours

Zeta Global Holdings (ZETA) reported Q2 net income late Tuesday of $8.17 million, swinging from the loss of $12.8 million a year earlier.Revenue in the three months ended June 30 rose to $442.8 million from $308.4 million a year earlier.Analysts surveyed by FactSet expected $420.6 million.The company expects Q3 revenue of $469 million to $472 million, up $10 million at the midpoint from the prior guidance of $461 million.Analysts project $461 million.Zeta boosted full-year guidance to GAAP EPS of $0.09 to $0.11 from the prior forecast of $0.02 to $0.04 on revenue of $1.811 billion to $1.824 billion, up $33 million at the midpoint from the previous projection of $1.785 billion.Analysts expect EPS of $0.04 on revenue of $1.79 billion.Zeta shares fell 6.8% in after-hours trading.

$ZETA
Wire

Voya Financial Q2 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Voya Financial (VOYA) reported Q2 adjusted net income late Tuesday of $1.51 per diluted share, down from $2.46 a year earlier.Analysts polled by FactSet expected $1.98.Revenue in the three months ended June 30 fell to $1.896 billion from $1.981 billion a year earlier.Analysts expected $1.897 billion.Voya shares fell 3.9% in after-hours trading.

$VOYA
Wire

Toast Q2 Earnings, Revenue Rise; Shares Drop After Hours

Toast (TOST) reported Q2 earnings late Tuesday of $0.26 per diluted share, up from $0.13 a year earlier.Analysts surveyed by FactSet expected $0.20.Revenue in the three months ended June 30 rose to $1.91 billion from $1.55 billion a year earlier.Analysts expected $1.87 billion.Toast shares fell 6.4% in after-hours trading.

$TOST